WO2023081802 - IL33 PROTEINS AND METHODS OF USE THEREOF
National phase entry:
Publication Number
WO/2023/081802
Publication Date
11.05.2023
International Application No.
PCT/US2022/079278
International Filing Date
04.11.2022
Title **
[English]
IL33 PROTEINS AND METHODS OF USE THEREOF
[French]
PROTÉINES IL33 ET LEURS MÉTHODES D'UTILISATION
Applicants **
MEMORIAL SLOAN KETTERING CANCER CENTER
Inventors
BALACHANDRAN, Vinod
MERGHOUB, Taha
Priority Data
63/275,835
04.11.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2347 | |
| EPO | Filing, Examination, Granting | 12769 | |
| Japan | Filing, Examination, Granting | 2076 | |
| South Korea | Filing, Examination, Granting | 1928 | |
| USA | Filing, Examination, Granting | 4310 |
Total:
23,430
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
In some embodiments the present invention provides methods and compositions for inducing the formation of de novo tertiary lymphoid structures in subjects. In some embodiments such methods comprise administering an IL33 protein to a subject. In some embodiments the subjects have cancer. In some embodiments the subjects have a chronic inflammatory condition. In some embodiments the present invention provides methods for treating cancer. In some embodiments the present invention provides methods for treating chronic inflammatory conditions.[French]
Dans certains modes de réalisation, la présente invention concerne des méthodes et des compositions pour induire la formation de structures lymphoïdes tertiaires de novo chez des sujets. Dans certains modes de réalisation, de telles méthodes comprennent l'administration d'une protéine IL33 à un sujet. Dans certains modes de réalisation, les sujets ont un cancer. Dans certains modes de réalisation, les sujets ont un état inflammatoire chronique. Dans certains modes de réalisation, la présente invention concerne des méthodes de traitement du cancer. Dans certains modes de réalisation, la présente invention concerne des méthodes de traitement d'états inflammatoires chroniques.